High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer:an open-label, randomised, phase 2 trial

Autor: Jens Engleson, Kristin Toftaker Killingberg, Georgios Tsakonas, Tesfaye Madebo, Øystein Fløtten, Seppo W. Langer, Odd Terje Brustugun, Signe Risum, Bjørn Henning Grønberg, Jan Nyman, Tarje Onsøien Halvorsen, Tine Schytte, Kjersti Hornslien

Publikováno v: Grønberg, B H, Killingberg, K T, Fløtten, Ø, Brustugun, O T, Hornslien, K, Madebo, T, Langer, S W, Schytte, T, Nyman, J, Risum, S, Tsakonas, G, Engleson, J & Halvorsen, T O 2021, ' High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer : an open-label, randomised, phase 2 trial ', Lancet Oncology, vol. 22, no. 3, pp. 321-331 . https://doi.org/10.1016/S1470-2045(20)30742-7
Grønberg, B H, Killingberg, K T, Fløtten, Ø, Brustugun, O T, Hornslien, K, Madebo, T, Langer, S W, Schytte, T, Nyman, J, Risum, S, Tsakonas, G, Engleson, J & Halvorsen, T O 2021, ' High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer : an open-label, randomised, phase 2 trial ', The Lancet Oncology, vol. 22, no. 3, pp. 321-331 . https://doi.org/10.1016/S1470-2045(20)30742-7

BACKGROUND: Concurrent chemoradiotherapy is standard treatment for limited stage small-cell lung cancer (SCLC). Twice-daily thoracic radiotherapy of 45 Gy in 30 fractions is considered to be the most effective schedule. The aim of this study was to i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1afdfffff1dfd163eae55d2c4e62564
https://curis.ku.dk/ws/files/333701537/High_dose_TRT_in_LS_SCLC_Gronberg_050920_002_.pdf

Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study

Autor: Michael Koller, Christian Schulz, Laura Gräfenstein, Colin D. Johnson, Marlene Hechtner, Lotte van der Weijst, Ofir Morag, Wolfgang Jungraithmayr, Georgios Ioannidis, Cecilia Pompili, Samantha Serpentini, Omar Shamieh, Wei-Chu Chie, Krzysztof A. Tomaszewski, Marianne Jensen Hjermstad, Karolina Müller, Annelies Janssens, Despina Katsochi, Kjersti Hornslien, Andrew Bottomley, Tara Chalk, Teresa Young, Monica Pinto, Amelie Harle, Juan Ignacio Arraras

Publikováno v: LANCET ONCOLOGY
The lancet oncology

Background The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Lung Cancer 13 (QLQ-LC13) assesses quality of life (QOL) in patients with lung cancer and was the first EORTC module developed for use in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31141a83038e3e6e728e54b41db9d9b9
https://doi.org/10.5167/uzh-193571

P1.01-09 Randomized Trial Comparing Maintenance Pemetrexed with Observation Followed by Pemetrexed at Progression in Advanced NSCLC

Autor: Kristin Stokke, Sveinung Sørhaug, Tesfaye Madebo, Kristin Toftaker Killingberg, S. Fluge, Tarje Onsøien Halvorsen, Sunil Xavier Raj, Kjersti Hornslien, Bjørn Henning Grønberg, Øystein Fløtten

Publikováno v: Journal of Thoracic Oncology. 14:S357-S358

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c7da713062032b06d55ab81d669196f9
https://doi.org/10.1016/j.jtho.2019.08.724

Potentially Curative Radiotherapy for Non–Small-Cell Lung Cancer in Norway: A Population-Based Study of Survival

Autor: Trond Eirik Strand, Stein Sundstrøm, Jarle Norstein, Andreas Stensvold, Kjersti Hornslien, Mari Wang, Paal Brunsvig, Oddveig Garpestad, Roy M. Bremnes, Dag Clement Johannessen

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 80:133-141

Purpose: The efficacy of curative irradiation in the treatment of non-small-cell lung cancer patients is considered limited. The purpose of this study was to evaluate long-term survival in a population-based approach. Methods and Materials: Cases of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d86f5259db3af58ce4d09612fac5c1d
https://doi.org/10.1016/j.ijrobp.2010.01.050

Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer

Autor: Bjørg Yksnøy Aksnessæther, Roy M. Bremnes, Ulf Aasebø, P. Brunsvig, Terje Tollåli, Kjersti Hornslien, Øystein Fløtten, Tarje Onsøien Halvorsen, Odd Terje Brustugun, Stein Sundstrøm, Bjørn Henning Grønberg, Erik Dyb Liaaen

Publikováno v: Acta Oncologica

Background: Concurrent chemotherapy and thoracic radiotherapy (TRT) is recommended for limited disease small cell lung cancer (LD SCLC). Twice daily TRT is well documented, but not universally implemented – probably mainly due to inconvenience and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32608469cab1520712101446725cf3d0
https://hdl.handle.net/10037/11755